Brian Schwartz
Chief Tech/Sci/R&D Officer at INTENSITY THERAPEUTICS, INC.
Net worth: 25 656 $ as of 30/04/2024
Network origin in Brian Schwartz first degree
Entity | Entity type | Industry | |
---|---|---|---|
University of Pretoria
29
| College/University | Other Consumer Services | 29 |
Public Company | Biotechnology | 17 | |
Public Company | Biotechnology | 14 | |
13
| Subsidiary | Pharmaceuticals: Major | 13 |
Public Company | Pharmaceuticals: Major | 10 | |
Extinct | Financial Conglomerates | 7 | |
Public Company | Pharmaceuticals: Major | 5 | |
Public Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Brian Schwartz via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
The Trustees of Columbia University in The City of New York | College/University | Undergraduate Degree Masters Business Admin Graduate Degree Undergraduate Degree Corporate Officer/Principal | |
OPKO Biologics Ltd.
OPKO Biologics Ltd. Pharmaceuticals: MajorHealth Technology OPKO Biologics Ltd. develops next-generation, bio-better, long-acting versions of therapeutic proteins and peptide drugs. Its products include Human Growth Hormone, Glucagon dual receptor agonist, Factor VIIa and Factor IX for Hemophilia, Anti-Obesity Peptide Oxyntomodulin, Interferon and Erythropoietin, and Atherosclerosis and Rheumatoid Arthritis long-acting therapies. The company was founded by Novik A. Shai on August 22, 2003 and is headquartered in Nes Ziona, Israel. | Pharmaceuticals: Major | Founder Chief Executive Officer Chief Executive Officer Director/Board Member | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
SASOL LIMITED | Chemicals: Major Diversified | Corporate Officer/Principal Chief Operating Officer Chief Executive Officer Chief Tech/Sci/R&D Officer | |
Phase4 Partners Ltd.
Phase4 Partners Ltd. Investment ManagersFinance Phase4 Ventures ltd (Phase4 Ventures) is a venture capital subsidiary of Nomura International Plc founded in 1999. The firm is headquartered in London, UK. | Investment Managers | Director/Board Member Private Equity Investor Director/Board Member | |
Prolor Biotech Ltd.
Prolor Biotech Ltd. BiotechnologyHealth Technology Prolor Biotech Ltd. develops proprietary versions of already-approved therapeutic proteins. The private company is based in Nes Ziona, Israel. | Biotechnology | Chief Executive Officer Corporate Officer/Principal Director of Finance/CFO | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
University of South Africa | College/University | Masters Business Admin Graduate Degree Undergraduate Degree | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Comptroller/Controller/Auditor | |
Weizmann Institute of Science | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
Harvard Medical School | College/University | Doctorate Degree Corporate Officer/Principal Doctorate Degree | |
Purdue University | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
The Pennsylvania State University | College/University | Graduate Degree Corporate Officer/Principal Undergraduate Degree | |
COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member Chairman Director/Board Member | |
The Johns Hopkins University | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
LifeSci Acquisition III Corp.
LifeSci Acquisition III Corp. Financial ConglomeratesFinance LifeSci Acquisition III Corp. operates as a blank check company with the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on December 18, 2019 and is headquartered in new York, NY. | Financial Conglomerates | Chief Executive Officer Chief Operating Officer Director of Finance/CFO | |
IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer General Counsel | |
Washington University in St. Louis | College/University | Undergraduate Degree Doctorate Degree | |
ICOS Corp.
ICOS Corp. Pharmaceuticals: OtherHealth Technology ICOS Corp. manufactures medications to treat inflammation and other serious diseases. It focuses on the development of treatments for unmet medical conditions such as prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. The company was founded in 1989 by Christopher Henney and George Rathman and is headquartered in Bothell, WA. | Pharmaceuticals: Other | Founder President | |
ESKOM HOLDINGS SOC LTD | Electric Utilities | Corporate Officer/Principal Chief Executive Officer | |
Sasol Olefins & Surfactants Pty Ltd. | Chief Executive Officer Chief Executive Officer | ||
The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
LifeSci Capital LLC
LifeSci Capital LLC Investment Banks/BrokersFinance LifeSci Capital LLC is a full-service investment bank that offers financial and strategic advisory services, institutional outreach, and research to leading life sciences companies. The private company is based in New York, NY. The company's team of investment bankers has extensive experience at bulge bracket and specialty investment banks. LifeSci Capital's highly regarded team of analysts generates differentiated, proprietary research and covers companies across all major therapeutic areas. The company was founded in 2013 by Andrew Ian McDonald and Michael Yehuda Rice. Andrew Ian McDonald has been the CEO since 2013. | Investment Banks/Brokers | Chief Executive Officer Founder | |
Tulane University (Louisiana) | College/University | Undergraduate Degree Undergraduate Degree | |
SYNGENE INTERNATIONAL LIMITED | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
SENSEI BIOTHERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
LifeSci Partners | Chief Executive Officer Founder | ||
PROTHENA CORPORATION PLC | Biotechnology | Director/Board Member Comptroller/Controller/Auditor | |
Lifesci Investments LLC | Corporate Officer/Principal Director/Board Member | ||
Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
University of Pennsylvania | College/University | Graduate Degree Doctorate Degree | |
LifeSci Venture Partners
LifeSci Venture Partners Investment ManagersFinance LifeSci Venture Partners (LifeSci Venture Partners) is a venture capital subsidiary of LifeSci Index Partners LLC founded in 2017 by Paul Inho Yook. The firm is headquartered in New York. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Lifesci Venture Management LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
LifeSci Advisors LLC
LifeSci Advisors LLC Miscellaneous Commercial ServicesCommercial Services LifeSci Advisors LLC is an investor relations consultancy founded to provide companies in the life sciences a comprehensive solution to investor communications and outreach. Their services are designed to increase clients? visibility within the investment community and to educate investors about the opportunity. | Miscellaneous Commercial Services | Founder Founder | |
Oncology Clinical Research & Development | Director/Board Member Director/Board Member | ||
LifeSci Index Partners LLC
LifeSci Index Partners LLC Investment ManagersFinance LifeSci Index Partners LLC (LSIP) is an independent investment advisor headquartered in New York City. The firm was co-founded by Paul Yook, Andrew McDonald and Michael Rice in 2014. LSIP is an index provider of healthcare-based stock market indices and also serves as the investment sub-advisor for the BioShares exchange traded funds. | Investment Managers | Chief Executive Officer Founder | |
NitroMed, Inc.
NitroMed, Inc. Pharmaceuticals: MajorHealth Technology NitroMed, Inc. develops and supplies pharmaceuticals. It offers BiDil, an orally administered medicine for the treatment of heart failure. The firm also develops products for cardiovascular and metabolic diseases. The company was founded in 1987 and is headquartered in Atlanta, GA. | Pharmaceuticals: Major | Chief Executive Officer Director of Finance/CFO | |
University of British Columbia | College/University | Doctorate Degree Undergraduate Degree | |
Weill Cornell Medical College | College/University | Corporate Officer/Principal Doctorate Degree |
Statistics
International
United States | 34 |
Israel | 8 |
South Africa | 5 |
United Kingdom | 4 |
India | 2 |
Sectoral
Consumer Services | 17 |
Health Technology | 16 |
Finance | 11 |
Commercial Services | 3 |
Process Industries | 2 |
Operational
Director/Board Member | 485 |
Corporate Officer/Principal | 177 |
Independent Dir/Board Member | 117 |
Chairman | 96 |
Undergraduate Degree | 84 |
Most connected contacts
Insiders | |
---|---|
Annalisa Jenkins | 51 |
Paul Blackburn | 46 |
Lauritz Dippenaar | 40 |
Michael Rice | 33 |
Johan van Zyl | 32 |
Roger Pomerantz | 30 |
Robert Spiegel | 30 |
Cornelius Theodorus Loock | 28 |
Jonas Grossman | 25 |
Edwin Allen Swiegers | 24 |
Susan Kelley | 22 |
Peter John Fellner | 21 |
Timothy Barabe | 21 |
Andrew McDonald | 19 |
Peter Bains | 19 |
- Stock Market
- Insiders
- Brian Schwartz
- Company connections